Prognostic value of stress cardiovascular magnetic resonance in patients with ischaemic heart disease and severely reduced left ventricular ejection fraction.
Ailís Ceara Haney, Janek Salatzki, Andreas Ochs, Thomas Hilbel, Lukas D Weberling, Hauke Hund, Evangelos Giannitsis, Norbert Frey, Henning Steen, Dirk Lossnitzer, Florian André
{"title":"Prognostic value of stress cardiovascular magnetic resonance in patients with ischaemic heart disease and severely reduced left ventricular ejection fraction.","authors":"Ailís Ceara Haney, Janek Salatzki, Andreas Ochs, Thomas Hilbel, Lukas D Weberling, Hauke Hund, Evangelos Giannitsis, Norbert Frey, Henning Steen, Dirk Lossnitzer, Florian André","doi":"10.1136/openhrt-2025-003466","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The concept of ischaemia for therapeutic guidance and risk stratification in coronary artery disease has been challenged in recent years. In particular, there is limited understanding of the prognostic value of ischaemia in patients with severely reduced left ventricular ejection fraction (LVEF). The aim of this study was to investigate the prognostic value of stress cardiovascular magnetic resonance (stress CMR) in patients with ischaemic heart disease (IHD) and severely reduced LVEF.</p><p><strong>Methods: </strong>This retrospective study included patients with IHD and an LVEF ≤35% who underwent stress CMR between 2009 and 2022. The primary endpoint was the occurrence of a major adverse cardiovascular event (MACE), including cardiac death, non-fatal myocardial infarction (MI), survived sudden cardiac death and implanted cardioverter defibrillator shock for ventricular fibrillation. The secondary combined endpoint included heart failure hospitalisation, percutaneous coronary intervention, arrhythmia and coronary artery bypass grafting (CABG). All-cause death was also documented.</p><p><strong>Results: </strong>The study population consisted of 362 patients (85.6% men, 70.5 (63.0-78.0) years) with an LVEF of 30.2% (25.2%-33.0%). 245 patients (67.6%) had three vessel disease, 206 patients (57.2%) had a history of MI and 83 patients (22.9%) had a history of CABG. Stress CMR showed ischaemia in 72 (19.9%) patients. Among those, 32 patients (8.8%) underwent early revascularisation. Follow-up was 4.5 (3.0-6.6) years. MACE occurred in 101 patients (27.9%), including 41 cases of cardiac death (11.3%) and 40 cases of MI (11.0%). Ischaemia was not significantly associated with MACE, the combined secondary endpoint, or all-cause death in survival analysis (HR for MACE 1.20, 95% CI 0.74 to 1.95, p=0.4).</p><p><strong>Conclusion: </strong>In a cohort of patients with IHD and severely reduced LVEF, outcome did not differ when stratifying by ischaemia on stress CMR. We found no evidence that ischaemia could identify patients with increased risk for MACE, the combined secondary endpoint or all-cause death.</p>","PeriodicalId":19505,"journal":{"name":"Open Heart","volume":"12 2","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12382561/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Heart","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/openhrt-2025-003466","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The concept of ischaemia for therapeutic guidance and risk stratification in coronary artery disease has been challenged in recent years. In particular, there is limited understanding of the prognostic value of ischaemia in patients with severely reduced left ventricular ejection fraction (LVEF). The aim of this study was to investigate the prognostic value of stress cardiovascular magnetic resonance (stress CMR) in patients with ischaemic heart disease (IHD) and severely reduced LVEF.
Methods: This retrospective study included patients with IHD and an LVEF ≤35% who underwent stress CMR between 2009 and 2022. The primary endpoint was the occurrence of a major adverse cardiovascular event (MACE), including cardiac death, non-fatal myocardial infarction (MI), survived sudden cardiac death and implanted cardioverter defibrillator shock for ventricular fibrillation. The secondary combined endpoint included heart failure hospitalisation, percutaneous coronary intervention, arrhythmia and coronary artery bypass grafting (CABG). All-cause death was also documented.
Results: The study population consisted of 362 patients (85.6% men, 70.5 (63.0-78.0) years) with an LVEF of 30.2% (25.2%-33.0%). 245 patients (67.6%) had three vessel disease, 206 patients (57.2%) had a history of MI and 83 patients (22.9%) had a history of CABG. Stress CMR showed ischaemia in 72 (19.9%) patients. Among those, 32 patients (8.8%) underwent early revascularisation. Follow-up was 4.5 (3.0-6.6) years. MACE occurred in 101 patients (27.9%), including 41 cases of cardiac death (11.3%) and 40 cases of MI (11.0%). Ischaemia was not significantly associated with MACE, the combined secondary endpoint, or all-cause death in survival analysis (HR for MACE 1.20, 95% CI 0.74 to 1.95, p=0.4).
Conclusion: In a cohort of patients with IHD and severely reduced LVEF, outcome did not differ when stratifying by ischaemia on stress CMR. We found no evidence that ischaemia could identify patients with increased risk for MACE, the combined secondary endpoint or all-cause death.
期刊介绍:
Open Heart is an online-only, open access cardiology journal that aims to be “open” in many ways: open access (free access for all readers), open peer review (unblinded peer review) and open data (data sharing is encouraged). The goal is to ensure maximum transparency and maximum impact on research progress and patient care. The journal is dedicated to publishing high quality, peer reviewed medical research in all disciplines and therapeutic areas of cardiovascular medicine. Research is published across all study phases and designs, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Opinionated discussions on controversial topics are welcomed. Open Heart aims to operate a fast submission and review process with continuous publication online, to ensure timely, up-to-date research is available worldwide. The journal adheres to a rigorous and transparent peer review process, and all articles go through a statistical assessment to ensure robustness of the analyses. Open Heart is an official journal of the British Cardiovascular Society.